Your browser doesn't support javascript.
loading
Methodological considerations on estimating medication adherence from self-report, electronic monitoring and electronic healthcare databases using the TEOS framework.
Dima, Alexandra L; Allemann, Samuel S; Dunbar-Jacob, Jacqueline; Hughes, Dyfrig A; Vrijens, Bernard; Wilson, Ira B.
Afiliación
  • Dima AL; Research and Development Unit, Institut de Recerca Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain.
  • Allemann SS; Pharmaceutical Care Research Group, University of Basel, Basel, Switzerland.
  • Dunbar-Jacob J; University of Pittsburgh School of Nursing, Pittsburgh, PA, USA.
  • Hughes DA; Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor, North Wales, UK.
  • Vrijens B; AARDEX Group & Department of Public Health, Liège University, Liège, Belgium.
  • Wilson IB; Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, RI, USA.
Br J Clin Pharmacol ; 89(7): 1918-1927, 2023 Jul.
Article en En | MEDLINE | ID: mdl-35491721
AIMS: Measuring adherence to medication is complex due to the diversity of contexts in which medications are prescribed, dispensed and used. The Timelines-Events-Objectives-Sources (TEOS) framework outlined a process to operationalize adherence. We aimed to develop practical recommendations for quantification of medication adherence using self-report (SR), electronic monitoring (EM) and electronic healthcare databases (EHD) consistent with the TEOS framework for adherence operationalization. METHODS: An adherence methodology working group of the International Society for Medication Adherence (ESPACOMP) analysed implications of the process of medication adherence for all data sources and discussed considerations specific to SR, EM and EHD regarding the information available on the prescribing, dispensing, recommended and actual use timelines, the four events relevant for distinguishing the adherence phases, the study objectives commonly addressed with each type of data, and the potential sources of measurement error and quality criteria applicable. RESULTS: Four key implications for medication adherence measurement are common to all data sources: adherence is a comparison between two series of events (recommended and actual use); it refers to one or more specific medication(s); it applies to regular repeated events coinciding with known recommended dosing; and it requires separate measurement of the three adherence phases for a complete picture of patients' adherence. We propose recommendations deriving from these statements, and aspects to be considered in study design when measuring adherence with SR, EM and EHD using the TEOS framework. CONCLUSION: The quality of medication adherence estimates is the result of several design choices that may optimize the data available.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Prescripciones de Medicamentos / Cumplimiento de la Medicación Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Br J Clin Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Prescripciones de Medicamentos / Cumplimiento de la Medicación Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Br J Clin Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: España